STAGE III RECTAL CANCER AJCC V7
Clinical trials for STAGE III RECTAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat colorectal cancer: targeted drug combo tested
Disease control CompletedThis study tested two different drug combinations in 240 people with advanced colorectal cancer that has a specific genetic change called HER2 amplification. One group received a combination of targeted antibodies (trastuzumab and pertuzumab), while the other received a standard …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 17, 2026 09:50 UTC
-
New combo therapy shows promise in shrinking rectal tumors
Disease control CompletedThis study tested whether adding the drugs veliparib or pembrolizumab to standard chemotherapy and radiation before surgery could improve outcomes for people with locally advanced rectal cancer. About 363 participants received one of these combinations. The goal was to shrink tum…
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 09:38 UTC